A Prospective Study of I.V. Vinflunine in the Treatment of Patients with Advanced or Metastatic Urothelial Carcinoma after Failure of a Platinum-containing Regimen and Biomarker Correlates
Background: Vinflunine is the only cytotoxic agent that had been tested as a second line therapy in platinum refractory urothelial carcinoma patients in a phase III clinical trial. The aim of our study was to evaluate the efficacy and safety of vinflunine as a second line after failure of platinum c...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
West Asia Organization for Cancer Prevention
2022-08-01
|
| Colección: | Asian Pacific Journal of Cancer Biology |
| Materias: | |
| Acceso en línea: | http://www.waocp.com/journal/index.php/apjcb/article/view/726 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|